Oxidative stress is a term frequently encountered in health and wellness discussions, but what does it truly mean for our bodies? In essence, oxidative stress occurs when there’s an imbalance between free radicals and antioxidants in your body. Free radicals are molecules with unpaired electrons, making them highly reactive. While they are a natural byproduct of metabolism and play roles in cell signaling, an overabundance can damage cells. Antioxidants are compounds that neutralize these free radicals, protecting cells from harm. When this balance tips in favor of free radicals, oxidative stress ensues, potentially leading to a range of health issues.
The Science Behind Oxidative Stress: Reactive Oxygen Species (ROS)
At the heart of oxidative stress are Reactive Oxygen Species (ROS). These include superoxide radicals (O2•−), hydrogen peroxide (H2O2), hydroxyl radicals (•OH), and singlet oxygen (1O2). ROS are produced as a natural consequence of metabolic processes within biological systems. They aren’t inherently harmful; in fact, at controlled levels, ROS are crucial for various physiological processes, including cell signaling, protein phosphorylation, immune function, and apoptosis. Think of them as cellular messengers and defense tools when present in moderation. However, when their production spirals out of control, the problems begin.
Mitochondria as the primary source of reactive oxygen species, highlighting their role in cellular energy production and ROS generation.
Mitochondria, the powerhouses of our cells, are significant contributors to ROS production. Cellular respiration within mitochondria naturally generates O2•−. Enzymes like lipoxygenases (LOX) and cyclooxygenases (COX), involved in arachidonic acid metabolism, also contribute to ROS. Even endothelial and inflammatory cells produce these reactive species. While mitochondria possess some intrinsic ROS scavenging capabilities, they can be overwhelmed when ROS production surges.
How Free Radicals are Produced: Enzymatic and Non-Enzymatic Reactions
The generation of ROS, and thus the potential for oxidative stress, stems from both enzymatic and non-enzymatic reactions within the body.
Enzymatic Reactions: Several enzyme-driven processes contribute to ROS production:
- Respiratory Chain: The electron transport chain in mitochondria, while essential for energy production, is a major source of superoxide radicals.
- Prostaglandin Synthesis: Enzymes involved in prostaglandin synthesis, like cyclooxygenases and lipoxygenases, generate ROS as byproducts.
- Phagocytosis: Immune cells like phagocytes intentionally produce ROS to destroy pathogens during the process of phagocytosis.
- Cytochrome P450 System: This system, crucial for detoxification and drug metabolism in the liver, also generates ROS.
Specific enzymes like NADPH oxidase, xanthine oxidase, and peroxidases are direct producers of superoxide radicals (O2•−). Superoxide then participates in further reactions, leading to the formation of other ROS like hydrogen peroxide (H2O2), hydroxyl radical (OH•), peroxynitrite (ONOO−), and hypochlorous acid (HOCl). Hydrogen peroxide, while not a radical itself, is produced by oxidase enzymes such as amino acid oxidase and xanthine oxidase. The hydroxyl radical (OH•), arguably the most reactive free radical in biological systems, is formed through the Fenton reaction, where superoxide radical reacts with hydrogen peroxide, catalyzed by iron (Fe2+) or copper (Cu+). Nitric oxide radical (NO•), while also a free radical, plays essential physiological roles and is synthesized by nitric oxide synthase (NOS) from arginine.
Non-Enzymatic Reactions: ROS production isn’t solely limited to enzyme activity. Non-enzymatic reactions also play a significant role:
- Reactions with Organic Compounds: Direct reactions between oxygen and organic molecules can generate free radicals.
- Ionizing Radiation Exposure: Exposure to ionizing radiation, such as UV or X-rays, can induce free radical formation in cells.
- Mitochondrial Respiration: Even during normal mitochondrial respiration, some non-enzymatic free radical production occurs.
Sources of Oxidative Stress: Endogenous and Exogenous Factors
Free radicals and subsequent oxidative stress can arise from both internal (endogenous) and external (exogenous) sources.
Endogenous Sources: These are factors originating within the body:
- Immune Cell Activation: Immune responses, while protective, can generate ROS as part of their defense mechanisms.
- Inflammation: Chronic inflammation is a significant driver of oxidative stress, as inflammatory processes produce ROS.
- Ischemia and Reperfusion: Conditions like stroke or heart attack, where blood supply is interrupted and then restored, can cause a surge in ROS production.
- Infection: Similar to immune activation, infections trigger ROS production as part of the body’s defense.
- Cancer: Cancer cells often exhibit increased ROS production and altered redox balance.
- Excessive Exercise: While beneficial in moderation, intense and prolonged exercise can temporarily increase ROS production.
- Mental Stress: Psychological stress can also contribute to oxidative stress in the body.
- Aging: The aging process itself is associated with a gradual increase in oxidative stress over time.
Exogenous Sources: These are external factors that we encounter in our environment or lifestyle:
- Environmental Pollutants: Air and water pollutants, including particulate matter and ozone, can induce oxidative stress.
- Heavy Metals: Exposure to heavy metals like cadmium (Cd), mercury (Hg), lead (Pb), iron (Fe), and arsenic (As) can significantly increase ROS production.
- Certain Drugs: Some medications, such as cyclosporine, tacrolimus, gentamycin, and bleomycin, are known to promote free radical generation.
- Chemical Solvents: Exposure to various chemical solvents can contribute to oxidative stress.
- Cooking Methods: Certain cooking practices like smoking meat, using old cooking oil, and high-fat cooking can generate free radicals.
- Cigarette Smoke: A major source of free radicals and a potent inducer of oxidative stress throughout the body.
- Alcohol: Excessive alcohol consumption can lead to increased ROS production and oxidative damage.
- Radiation: Exposure to UV and ionizing radiation from sunlight or medical treatments.
When these exogenous compounds enter the body, they are metabolized or broken down, often resulting in free radicals as byproducts, further contributing to oxidative stress.
The Dual Nature of Free Radicals: Physiological Roles vs. Detrimental Effects
While often portrayed negatively, free radicals and ROS are not inherently harmful. They play crucial roles in maintaining health when kept in balance.
Beneficial Roles of Free Radicals:
- Immune Defense: Phagocytes, a type of immune cell, use ROS to destroy invading pathogens. Patients with granulomatous disease, who have impaired NADPH oxidase and cannot produce superoxide, suffer from recurrent infections, highlighting the importance of ROS for immune function.
- Cellular Signaling: ROS act as signaling molecules in various cellular pathways, regulating processes like cell growth, differentiation, and apoptosis. Nitric oxide (NO), a well-known free radical, is a vital signaling molecule involved in blood flow regulation, nerve function, and immune defense.
- Mitogenic Response: Free radicals can stimulate cell growth and proliferation, contributing to tissue repair and regeneration.
Visual representation of the dual role of free radicals, illustrating their beneficial functions at balanced levels and harmful effects when excessive, leading to oxidative stress.
Detrimental Effects of Excess Free Radicals: Oxidative Stress
When the production of free radicals overwhelms the body’s antioxidant defenses, oxidative stress occurs. This imbalance leads to damage to critical cellular components:
- Lipid Peroxidation: Excess ROS, particularly hydroxyl radicals and peroxynitrite, can attack lipids in cell membranes and lipoproteins, causing lipid peroxidation. This chain reaction damages membranes, produces cytotoxic and mutagenic compounds like malondialdehyde (MDA), and contributes to diseases like atherosclerosis.
- Protein Damage: Oxidative stress can alter protein structure, leading to conformational changes and loss or impairment of enzymatic activity. Damaged proteins can accumulate and disrupt cellular function.
- DNA Damage: DNA is particularly vulnerable to oxidative damage. The formation of 8-oxo-2′-deoxyguanosine (8-OHdG) is a common and significant DNA lesion caused by oxidative stress. 8-OHdG can lead to mutations, impacting gene expression and potentially contributing to cancer development. Elevated 8-OHdG levels are even considered a biomarker of oxidative stress.
Cells have defense mechanisms like base excision repair (BER) and endogenous antioxidants to counteract DNA damage, but these systems can be overwhelmed by excessive oxidative stress. Uncontrolled oxidative stress is implicated in a wide range of chronic and degenerative diseases, accelerates aging, and contributes to acute conditions like trauma and stroke.
Diseases Linked to Oxidative Stress: A Broad Spectrum of Health Issues
Oxidative stress is not just a cellular phenomenon; it’s a significant factor in the development and progression of numerous diseases.
Cancer and Oxidative Stress
Oxidative DNA damage is a well-established contributor to cancer development. Chromosomal abnormalities and oncogene activation, driven by oxidative stress, can initiate or promote cancer. Oxidative damage to DNA bases is a key event in chemical carcinogenesis, disrupting normal cell growth and causing mutations. Sources of oxidative DNA damage, like tobacco smoke, pollutants, and chronic inflammation, are also known cancer risk factors. Lifestyle factors, such as high dietary fat intake, which increases lipid peroxidation, are also linked to higher cancer mortality rates.
Cardiovascular Disease and Oxidative Stress
Oxidative stress is considered a primary or secondary cause in many cardiovascular diseases (CVDs). It plays a crucial role in atherosclerosis, the formation of plaques in arteries. Endothelial inflammation, a precursor to atherosclerosis, triggers ROS production by macrophages. ROS oxidize LDL cholesterol, leading to foam cell formation and plaque development. Oxidative stress is implicated in various CVDs, including atherosclerosis, ischemia, hypertension, cardiomyopathy, cardiac hypertrophy, and heart failure.
Neurological Disease and Oxidative Stress
Neurodegenerative diseases like Parkinson’s disease, Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), multiple sclerosis, depression, and memory loss are linked to oxidative stress. In AD, oxidative damage is believed to be a key factor in neuron loss and dementia progression. β-amyloid, a peptide associated with AD, is produced by free radical action and contributes to neurodegeneration.
Respiratory Disease and Oxidative Stress
Lung diseases like asthma and chronic obstructive pulmonary disease (COPD) are associated with both systemic and local chronic inflammation, and oxidative stress is a significant component. Oxidants exacerbate inflammation by activating signaling pathways and transcription factors like NF-kappa B and AP-1.
Rheumatoid Arthritis and Oxidative Stress
Rheumatoid arthritis, a chronic inflammatory joint disorder, is also linked to oxidative stress. Free radicals at the inflammation site contribute to the initiation and progression of the disease, evidenced by increased levels of isoprostanes and prostaglandins in the synovial fluid of affected individuals.
Kidney Diseases and Oxidative Stress
Oxidative stress is implicated in various kidney diseases, including glomerulonephritis, tubulointerstitial nephritis, renal failure, proteinuria, and uremia. ROS production in the kidneys promotes inflammation and the production of pro-inflammatory cytokines. Chronic oxidative stress can lead to fibrosis and ultimately impair kidney function, potentially resulting in renal failure. Certain nephrotoxic drugs and heavy metals exacerbate kidney damage through oxidative stress mechanisms.
Sexual Maturation and Oxidative Stress
Emerging research suggests oxidative stress might play a role in delayed sexual maturation and puberty onset. Exposure to cadmium, a known inducer of oxidative stress, in prepubertal children and pregnant women has been linked to these developmental delays.
In summary, oxidative stress is a pervasive factor contributing to a wide range of pathological conditions, impacting various tissues and systems throughout the body and posing a significant threat to human health.
Exogenous Antioxidants: Dietary Allies Against Oxidative Stress
The body has its own endogenous antioxidant defenses, including enzymes like superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), and non-enzymatic antioxidants like lipoic acid, glutathione, L-arginine, and coenzyme Q10. However, exogenous antioxidants, obtained from our diet or supplements, are also crucial for bolstering these defenses.
Vitamin E
Vitamin E is a group of fat-soluble compounds including tocopherols and tocotrienols, found in plant-based foods like oils and seeds. Alpha-tocopherol is the most active form and has shown antioxidant and anti-inflammatory effects.
- Cardiovascular Health: Vitamin E can inhibit the proliferation of vascular smooth muscle cells, a key process in atherosclerosis. It also reduces macrophage transformation into foam cells by interfering with CD36 receptor expression, which is involved in oxidized-LDL uptake. Vitamin E supplementation has shown promise in animal models of atherosclerosis.
- Inflammation Modulation: Vitamin E can modulate the NF-κB pathway, reducing inflammation and monocyte invasion.
- Tocopherol Forms and Differing Effects: Different forms of vitamin E, like alpha-tocopherol and gamma-tocopherol, can have contrasting effects, particularly in inflammation. Gamma-tocopherol, while also an antioxidant, has shown pro-inflammatory effects in allergic inflammation and may negatively impact lung function at high levels. This highlights the complexity of antioxidant supplementation and the importance of considering different forms of vitamin E.
Flavonoids
Flavonoids are polyphenolic compounds abundant in plants, known for their antioxidant properties. They act by scavenging free radicals and chelating metal ions, thanks to their hydroxyl groups.
- Antioxidant Mechanisms: Flavonoids can suppress ROS synthesis, scavenge existing ROS, and enhance the body’s antioxidant defenses.
- Genistein Example: Genistein, a soy isoflavone, is a well-studied flavonoid with potent antioxidant and anti-inflammatory effects. It can improve cellular antioxidant defenses, protect against lipoprotein oxidation, and potentially reduce oxidative DNA damage. Genistein also inhibits NF-κB activation and can increase antioxidant enzyme expression.
Flavonoids, widely present in fruits, vegetables, and plant-based foods, offer significant potential health benefits as antioxidants and anti-inflammatory agents. However, careful consideration is needed when using them as supplements, as their effects can be complex.
Prooxidant Agents in Therapy: Harnessing Oxidative Stress for Good
Paradoxically, prooxidant agents, substances that promote oxidation and ROS production, are being explored and used therapeutically, particularly in cancer treatment.
Ascorbic Acid (Vitamin C)
While known as an antioxidant, ascorbic acid (vitamin C) can act as a prooxidant under certain conditions.
- Prooxidant Mechanism: Ascorbate can reduce metal ions, leading to the Fenton reaction and the generation of highly reactive hydroxyl radicals. These radicals can induce cytotoxicity, particularly in cancer cells.
- Cancer Therapy Potential: Cancer cells, often with compromised antioxidant defenses, are more susceptible to the prooxidant effects of high-dose ascorbic acid. Ascorbate can induce apoptosis in cancer cells through ROS-mediated pathways. While promising in vitro and some animal studies, more research is needed to fully understand its efficacy and mechanisms as a prooxidative anticancer agent in humans.
Polyphenols as Prooxidants
Similar to vitamin C, polyphenols can also exhibit prooxidant behavior under specific conditions, such as high concentrations or in the presence of redox-active metals.
- Prooxidant Mechanisms: Polyphenols can generate aroxyl radicals, leading to superoxide radical production. They can also induce oxidative stress through interactions with transition metals, which are often elevated in cancer cells, generating hydroxyl radicals via Fenton-like reactions.
- Anticancer Effects: Prooxidant polyphenols can induce apoptosis and cell cycle arrest in cancer cells through ROS-mediated pathways. Anthocyanins, esculetin, and curcumin are examples of polyphenols that have shown prooxidative anticancer activity in preclinical studies. However, more in vivo research is needed to fully elucidate their prooxidant mechanisms and therapeutic potential in cancer.
Radiation Therapy: A Prooxidant Approach
Radiation therapy, a cornerstone of cancer treatment, works by inducing oxidative stress in cancer cells.
- Mechanism of Action: Ionizing radiation generates free radicals that damage DNA, particularly causing double-strand breaks (DSBs). This DNA damage is a major mechanism by which radiation therapy destroys cancer cells.
- DNA Damage Response: Cells respond to radiation-induced DNA damage by activating complex DNA damage response (DDR) pathways, which can lead to cell cycle arrest, apoptosis, or other forms of cell death.
- Targeted Radiotherapy: Modern radiotherapy techniques like intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT) aim to precisely target radiation to cancer cells, minimizing damage to healthy tissues and reducing side effects associated with oxidative stress in normal cells.
Conclusion: Navigating the Complex Landscape of Oxidative Stress
Oxidative stress is a fundamental concept in biology and medicine, representing an imbalance with significant health implications. While often viewed as detrimental, free radicals and oxidative stress are not entirely negative. They play essential physiological roles, and in some cases, harnessing prooxidant mechanisms can be therapeutically beneficial, as seen in cancer treatment.
Antioxidants are crucial for mitigating excessive oxidative stress and protecting against disease. However, the story is not always straightforward. As seen with different forms of vitamin E and the prooxidant potential of vitamin C and polyphenols, the effects of antioxidants and prooxidants can be nuanced and context-dependent.
Ultimately, maintaining a balance is key. Supporting the body’s endogenous antioxidant systems through a healthy lifestyle, a diet rich in diverse antioxidants, and minimizing exposure to exogenous sources of oxidative stress are vital for promoting overall health and well-being. Further research into the complexities of oxidative stress and the therapeutic potential of both antioxidants and prooxidants holds promise for improving human health and treating disease.
References
[1] Halliwell B, Gutteridge JM. Free radicals in biology and medicine. Oxford university press; 2015.
[2] Sies H. Oxidative stress: a concept in redox biology and medicine. Redox biology. 2015 Jun 1;4:180-3.
[3] Dröge W. Free radicals in the physiological control of cell function. Physiological reviews. 2002 Jan 1.
[4] Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacognosy reviews. 2010 Sep;4(8):118.
[5] Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked?. Free radical biology and medicine. 2010 Dec 1;49(11):1603-16.
[6] Li Y, Huang TT, Jiang Y, Wang DD, Yang XL, Kong XL, Cao HX, Chen XQ, Ouyang YY, Wang RT, Hu YY. Reactive oxygen species regulate TNF-α-induced ICAM-1 expression and endothelial inflammation via c-Src-mediated signaling pathway. Journal of cellular physiology. 2012 Jul;227(7):2805-14.
[7] Murphy MP. How mitochondria produce reactive oxygen species. Biochemical Journal. 2009 Feb 1;417(1):1-3.
[8] Lenaz G, Genova ML. Mitochondrial bioenergetics and degenerative diseases. Mitochondrion. 2010 Dec 1;10(6):607-14.
[9] McCord JM, Fridovich I. Superoxide dismutase. J Biol Chem. 1969 Nov 10;244(22):6049-55.
[10] Babior BM. NADPH oxidase. Blood. 1999 Mar 15;93(5):1464-76.
[11] Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. The American journal of cardiology. 2003 Feb 15;91(4A):7A-11A.
[12] Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. The international journal of biochemistry & cell biology. 2007;39(1):44-84.
[13] Halliwell B. Reactive species and antioxidants. Redox biology is more complicated than you might think. British journal of pharmacology. 2007 Jan;150(1):2-2.
[14] Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: report of a general discussion at the 7th Biennial Meeting of the Society for Free Radical Research-International, Versailles, 2004. Free Radical Research. 2004 Nov 15;38(11):1115-21.
[15] Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. International journal of biomedical science: IJBS. 2008 Jun;4(2):89.
[16] Sies H. Oxidative stress: oxidants and antioxidants. Experimental physiology. 1997 Jul;82(2):291-5.
[17] Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 1999 Dec 1;424(1-2):139-54.
[18] Madamanchi NR, Runge MS. Redox signaling in cardiovascular disease. Arteriosclerosis, thrombosis, and vascular biology. 2007 Feb;27(2):253-9.
[19] Finkel T. Signal transduction by reactive oxygen species. Journal of molecular cell biology. 2011 Dec 1;3(6):346-50.
[20] Stadtman ER. Protein oxidation and aging. Free radical research. 2006 Jul 1;40(12):1250-8.
[21] Yu BP. Oxidative stress, aging, and diseases. Annals of the New York Academy of Sciences. 1994 Jun;717(1):1-1.
[22] Klaunig JE, Kamendulis JR, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicologic pathology. 2010 Jan;38(1):96-109.
[23] Ercal N, Gurer-Orhan H, Aykin-Burns N. Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Current pharmaceutical design. 2001 Sep 1;7(12):1121-52.
[24] Luo J, Jiang J, Chen Y, Tian L, Song J, Wang Z. Oxidative stress and antioxidant defense system in bleomycin-induced lung injury. Toxicology letters. 2017 Jan 5;265:28-35.
[25] Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative medicine and cellular longevity. 2014;2014.
[26] Nishida J, Nishida Y, Mori T, Kawai S. 8-Hydroxydeoxyguanosine is associated with mutagenesis by oxidative stress. Free radical biology and medicine. 2014 Dec 1;77:95-103.
[27] Valavanidis A, Vlachogianni T, Fenga C. 8-hydroxy-2′-deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. Journal of molecular biochemistry. 2009;3(2):72.
[28] Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, measurement and significance. The FASEB Journal. 2003 Apr;17(9):1195-214.
[29] Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and cancer. Biochemical Journal. 1996 Apr 15;313(2):17-29.
[30] Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005 May 10;111(25):3481-8.
[31] Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007 Feb 6;115(9):1285-95.
[32] Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nature reviews Drug discovery. 2004 Oct;3(10):205-16.
[33] Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. science. 1993 Oct 1;262(5134):689-95.
[34] Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba T, Kawaguchi M, Petersen RB, Smith MA. RNA oxidation is a prominent feature of early Alzheimer’s disease pathology. Journal of Neuroscience. 1999 Jul 15;19(15):1959-64.
[35] Butterfield DA, Reed T, Perluigi M, De Marco C, Coccia R, Keller JN, Markesbery WR, Rossi G, Arcelli P, Galli F. Elevated levels of 3-nitrotyrosine and protein-associated carbonyls in brain from patients with Alzheimer’s disease. Brain research. 2001 Oct 12;908(2):249-52.
[36] Rahman I, MacNee W. Role of oxidants in pathogenesis of chronic obstructive pulmonary disease: therapeutic implications. The Lancet. 1996 Sep 21;348(9031):823-7.
[37] Barnes PJ. Oxidative stress and asthma. American journal of respiratory and critical care medicine. 1999 Oct 1;160(5 Pt 2):S48-52.
[38] Li XY, Wilson JW. Oxidant stress and oncogenic signaling in lung cancer. Seminars in cancer biology. 2008 Dec 1;18(6):387-94.
[39] Chung KF, Adcock IM. Multifaceted mechanisms in severe asthma: therapeutic implications. European Respiratory Journal. 2008 Nov 1;32(5):1343-55.
[40] Harris ED. Rheumatoid arthritis. Pathophysiology and implications for therapy. New England Journal of Medicine. 1990 Jul 19;322(18):1277-89.
[41] Mateen S, Moin S, Khan AQ, Zafar A, Fatima N. Oxidative stress and antioxidant parameters in rheumatoid arthritis: a systematic review and meta-analysis. PloS one. 2016 Jul 7;11(7):e0158192.
[42] Nath KA. Role of reactive oxygen species in progressive renal injury. The American journal of kidney diseases. 1995 Sep 1;26(3):S41-6.
[43] Lieberthal W, Fuhro R. Cyclosporine nephrotoxicity. Drug safety. 1992 Nov;7(6):434-49.
[44] Tune BM, Hsu CY. Mechanisms of aminoglycoside nephrotoxicity. Journal of the American Society of Nephrology. 1990 Feb 1;1(2):126-32.
[45] Ishikawa T, Sekizawa K, Morikawa T, Katoh O, Yanagisawa M, Yoshizawa Y. Bleomycin-induced pneumopathy and free radicals. Nihon Kyobu Shikkan Gakkai zasshi. 1992 Apr;30(4):631-6.
[46] Ronchetti RC, Lucarini N, Catino M, Fazzini PF, Annibalini G, Galeazzi T, Ferroni L, Rossi R, Diamanti A, Falconi G, Cocci P. Prepubertal cadmium exposure and oxidative stress affect rat testis development and function. Toxicology letters. 2017 Jan 5;265:1-10.
[47] Kippler M, Tofail F, Gardner RM, Nahar N, Bottai M, Hamadani JD, Vahter M. Maternal cadmium exposure in early pregnancy and child neurodevelopment at 5 years: prospective cohort study. Environmental health perspectives. 2012 Jul;120(7):1031-6.
[48] Kamal-Eldin A, Appelqvist LA. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids. 1996 Oct;31(3):671-701.
[49] Brigelius-Flohé R, Traber MG. Vitamin E: function and metabolism. The FASEB Journal. 1999 Jul;13(10):1145-55.
[50] Traber MG. Vitamin E regulatory mechanisms. Annual review of nutrition. 2007 Jul 17;27:347-62.
[51] Keaney Jr JF, Simon DI, Freedman JE, Zeng YH, Creager MA, Vita JA. Vitamin E inhibits cytokine-induced E-selectin expression in and leukocyte adhesion to endothelial cells. Journal of Clinical Investigation. 1993 Sep 1;92(2):386.
[52] Wu IH, Moriwaki H, Berti AA, Simon DI, Keaney Jr JF, Ishikawa T, Frei B. Vitamin E inhibits lipoprotein oxidation and monocyte adhesion to human aortic endothelial cells induced by mildly oxidized low-density lipoproteins. Arteriosclerosis, thrombosis, and vascular biology. 1996 Nov;16(11):1384-91.
[53] Williams RJ, Motteram JM, Sharp CH, Gallagher PJ, Scott DL, Stocks J, Bruckdorfer KR. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits with homozygous familial hypercholesterolemia. Atherosclerosis. 1994 Aug 1;108(2):235-48.
[54] Verlangieri AJ, Bush MJ. Effects of d-α-tocopherol on serum lipids, lipoproteins, and the development of atherosclerosis in cholesterol-fed rabbits. Journal of the American College of Nutrition. 1992 Jun 1;11(3):131-8.
[55] Thomas SR, Witting PA, Drummond GR, Jessup W, Rye KA, Stocker R. α-Tocopherol decreases lipid peroxidation in murine macrophages but not early atherosclerosis in apolipoprotein E-deficient mice. Arteriosclerosis, thrombosis, and vascular biology. 1998 Jan;18(1):58-66.
[56] Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, inflammation, atherosclerosis, and lipid metabolism. Journal of Clinical Investigation. 2001 Nov 15;108(6):785.
[57] Silverstein RL, Febbraio M. CD36, a scavenger receptor for oxidized lipoproteins. Arteriosclerosis, thrombosis, and vascular biology. 2000 Feb;20(2):342-8.
[58] Devaraj S, Jialal I. α-Tocopherol supplementation decreases monocyte adhesion to human endothelial cells. The Journal of the American College of Nutrition. 2000 Dec 1;19(6):720-7.
[59] Devaraj S, Jialal I. Vitamin E inhibits cholesterol-induced CD36 expression in human macrophages. Journal of lipid research. 2000 Oct 1;41(10):1607-13.
[60] Ivanov AV, Zilinskaya OV, Myasnikova VV, Ivanova EA, Orekhov AN. Vitamin E upregulates PPARγ and LXRα and stimulates ABCA1 expression in macrophages. The Journal of Nutritional Biochemistry. 2010 Aug 1;21(8):714-21.
[61] Weber C, Erl W, Pietsch A, Weber PC, Neumeier D. Vitamin E suppresses cytokine-induced NF-κB activation in endothelial cells. Journal of vascular research. 1995;32(4):259-67.
[62] Liu ML, Niu X, Zhang X, Disilvestro RA, Song Y, White WL, Jiang Q. γ-and δ-tocopherols but not α-tocopherol inhibit cyclooxygenase-2 expression in macrophages. Lipids. 2008 Sep;43(9):805-14.
[63] Wu D, Meydani M. γ-Tocopherol and δ-tocopherol are more effective than α-tocopherol in inhibiting cyclooxygenase-2 and inflammatory cytokine production in macrophages. The Journal of nutrition. 2004 Oct 1;134(10):2497-504.
[64] Ricciarelli R, Zingg JM, Azzi A. Vitamin E: protective role in atherosclerosis. Annals of the New York Academy of Sciences. 2004 Dec;1031(1):95-107.
[65] Zingg JM, Ricciarelli R, Corsetto AG, Kramer K, Azzi A. α-Tocopherol is a potent inhibitor of smooth muscle cell proliferation. Free radical biology and medicine. 2003 Apr 1;34(8):1027-37.
[66] Lee E, Koo J, Jang Y, Lee J, Lee H, Park D. Vitamin E supplementation improves insulin resistance and oxidative stress in obese Korean children. Nutrition research and practice. 2015 Dec;9(6):612.
[67] Wu D, Song Y, Meydani M. γ-tocopherol and δ-tocopherol but not α-tocopherol increase NO production in RAW 264.7 macrophages. The Journal of nutrition. 2006 Feb 1;136(2):313-9.
[68] Jiang Q, Christen S, Shigenaga MK, Ames BN. γ-tocopherol, but not α-tocopherol, decreases cyclooxygenase-2 protein and prostaglandin E 2 levels in macrophages. The FASEB Journal. 2000 Aug;14(10):180
